• There are no items in your cart

CLSI M100 S17 : 17ED 2007

Superseded

Superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View Superseded by
superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING

Superseded date

30-12-2008

Published date

12-01-2013

Abstract
Committee Membership
Foreword
1 Scope
2 Safety and Standard Precautions
  2.1 Risk Assessment
  2.2 Biosafety Levels-General
  2.3 Additional Aspects of Biosafety Pertinent to
      Mycobacteriology
3 Levels of Laboratory and Referral Services
4 Clinical Significance of Mycobacterium spp
  4.1 Clinical Setting/Pathogenicity
  4.2 Laboratory Indicators
5 Specimen Types, Collection, Transport, and Storage
6 Specimen Processing
7 Detection of Mycobacteria
  7.1 Microscopy
  7.2 Nucleic Acid Amplification Tests (NAATs) For Direct
      Detection of M. tuberculosis Complex in Clinical
      Specimens
  7.3 Detection of Mycobacteria by Culture
8 Identification Procedures
  8.1 Phenotypic Methods
  8.2 Genotypic Methods
References
Appendix A. Final Rule, Department of Transportation Pipeline
            and Hazardous Materials Safety Administration,
            Hazardous Materials: Infectious Substances;
            Harmonization With the United Nations
            Recommendations, June 7, 2006
Appendix B. Methods for Digestion and Decontamination
Appendix C. Staining Procedures
Appendix D. Preparation and Storage of Quality Control Organisms
Appendix E. Biochemical Procedures
The Quality System Approach
Related CLSI/NCCLS Publications

Provides updated tables for the Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing standards M2-A9 and M7-A7.

DevelopmentNote
Supersedes NCCLS M100 S16. Not available separately, Included in packages of: NCCLS M7 A7 and NCCLS M100 S17. NCCLS M2 A9, NCCLS M7 A7 and NCCLS M100 S17. NCCLS M2 A9 and NCCLS M100 S17. (02/2007)
DocumentType
Miscellaneous Product
PublisherName
Clinical Laboratory Standards Institute
Status
Superseded
SupersededBy
Supersedes

CLSI M23 A3 : 3ED 2008 DEVELOPMENT OF IN VITRO SUSCEPTIBILITY TESTING CRITERIA AND QUALITY CONTROL PARAMETERS

CLSI M24 A : 1ED 2003 SUSCEPTIBILITY TESTING OF MYCOBACTERIA, NOCARDIA, AND OTHER AEROBIC ACTINOMYCETES
CLSI M22 A3 : 3ED 2004 QUALITY CONTROL FOR COMMERCIALLY PREPARED MICROBIOLOGICAL CULTURE MEDIA

View more information
Sorry this product is not available in your region.

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.